Journal Mobile Options
Table of Contents
Vol. 80, No. 4, 1988
Issue release date: 1988
Acta Haematol 1988;80:224
(DOI:10.1159/000205644)

Acute Lymphoblastic Leukemia and Sweet’s Syndrome

Tuncer A.M.
Department of Pediatric Hematology, University of Hacettepe, Ankara, Turkey
email Corresponding Author


 Outline


 goto top of outline Author Contacts

A. Murat Tuncer, MD, Associated Prof, of Pediatrics, University of Hacettepe, Hacettepe Children’s Hospital, Department of Pediatric Hematology, Ankara (Turkey)


 goto top of outline Article Information

Accepted: July 26, 1988
Published online: February 24, 2009
Number of Print Pages : 1


 goto top of outline Publication Details

Acta Haematologica

Vol. 80, No. 4, Year 1988 (Cover Date: 1988)

Journal Editor: Ben-Bassat I. (Qiryat-Ono)
ISSN: 0001-5792 (Print), eISSN: 1421-9662 (Online)

For additional information: http://www.karger.com/AHA


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

First-Page Preview
Abstract of Correspondence

 goto top of outline Author Contacts

A. Murat Tuncer, MD, Associated Prof, of Pediatrics, University of Hacettepe, Hacettepe Children’s Hospital, Department of Pediatric Hematology, Ankara (Turkey)


 goto top of outline Article Information

Accepted: July 26, 1988
Published online: February 24, 2009
Number of Print Pages : 1


 goto top of outline Publication Details

Acta Haematologica

Vol. 80, No. 4, Year 1988 (Cover Date: 1988)

Journal Editor: Ben-Bassat I. (Qiryat-Ono)
ISSN: 0001-5792 (Print), eISSN: 1421-9662 (Online)

For additional information: http://www.karger.com/AHA


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.